Systemic Role for Vitamin D in the Treatment of Psoriasis and Metabolic Syndrome
The novel discovery of the systemic role of vitamin D in the modulation of the immune system especially the Type 1 helper T cell (Th1) pathway reveals its potential for treating Th1 inflammatory diseases. Psoriasis has been recently established to be a systemic disease centered on inflammation and i...
Saved in:
Main Authors: | Lisa Wenyang Fu, Ronald Vender |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2011-01-01
|
Series: | Dermatology Research and Practice |
Online Access: | http://dx.doi.org/10.1155/2011/276079 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prevalence of Metabolic Syndrome in Patients with Psoriasis
by: Ilkin Zindancı, et al.
Published: (2012-01-01) -
The Impact of Psoriasis and Metabolic Syndrome on the Systemic Inflammation and Oxidative Damage to Nucleic Acids
by: Drahomira Holmannova, et al.
Published: (2020-01-01) -
The Combined Use of Metformin and Methotrexate in Psoriasis Patients with Metabolic Syndrome
by: Huynh Thi Xuan Tam, et al.
Published: (2022-01-01) -
Effect of Vitamins A, C, and E Supplementation in the Treatment of Metabolic Syndrome in Albino Rats
by: L. S. Bilbis, et al.
Published: (2012-01-01) -
Prevalence of metabolic syndrome with different serum vitamin D levels in middle-aged and older adults
by: Ya Zhao, et al.
Published: (2025-01-01)